menu
    • menu

    Company profile for Innate Pharma

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Innate Pharma works on an innovative approach against cancer: monoclonal antibodies designed to stimulate anti-tumor activity of NK cells and other cells of the innate immune system. Immuno-oncology is changing cancer treatment by harnessing the power of the body’s immune system to recognize and kill cancer cells. This approach aims at restoring immune surveillance and can lead to durable responses in some patients who have...
    Innate Pharma works on an innovative approach against cancer: monoclonal antibodies designed to stimulate anti-tumor activity of NK cells and other cells of the innate immune system. Immuno-oncology is changing cancer treatment by harnessing the power of the body’s immune system to recognize and kill cancer cells. This approach aims at restoring immune surveillance and can lead to durable responses in some patients who have failed all available conventional therapies. One of the greatest advances in immuno-oncology involves the use of checkpoint inhibitors.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Innate PharmaFrance Flag
    Country
    Country
    France
    Address
    Address
    117, Avenue de Luminy - BP 30191 13 009 Marseille
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.innate-pharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Innate Pharma Reports Shares, Voting Rights as of Dec. 18
    Innate Pharma Reports Shares, Voting Rights as of Dec. 18

    22 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251221727031/en/Number-of-Shares-and-Voting-Rights-of-Innate-Pharma-as-of-December-18-2025

    BUSINESSWIRE
    22 Dec 2025
    Share Share
    Innate Pharma Releases Its 2026 Financial Calendar
    Innate Pharma Releases Its 2026 Financial Calendar

    11 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-11/innate-pharma-releases-its-2026-financial-calendar

    PHARMIWEB
    11 Dec 2025
    Share Share
    Innate Pharma Reports Shares, Voting Rights as of Nov. 27
    Innate Pharma Reports Shares, Voting Rights as of Nov. 27

    28 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251127730070/en/Number-of-Shares-and-Voting-Rights-of-Innate-Pharma-as-of-November-27-2025

    BUSINESSWIRE
    28 Nov 2025
    Share Share
    Innate Pharma to Present at Jefferies Healthcare Conference
    Innate Pharma to Present at Jefferies Healthcare Conference

    17 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251116037317/en/Innate-Pharma-to-Present-at-Jefferies-Global-Healthcare-Conference

    BUSINESSWIRE
    17 Nov 2025
    Share Share
    Innate Pharma Updates Q3 2025 Business And Financials
    Innate Pharma Updates Q3 2025 Business And Financials

    13 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251112563057/en/Innate-Pharma-Reports-Third-Quarter-2025-Business-Update-and-Financial-Results

    BUSINESSWIRE
    13 Nov 2025
    Share Share
    Innate Pharma Announces FDA Clearance to Proceed With TELLOMAK 3
    Innate Pharma Announces FDA Clearance to Proceed With TELLOMAK 3

    10 Nov 2025

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20251109757297/en/Innate-Pharma-Announces-FDA-Clearance-to-Proceed-With-TELLOMAK-3-a-Confirmatory-Phase-3-Trial-of-Lacutamab-in-CTCL

    BUSINESS WIRE
    10 Nov 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search